Clinical Trials List
Protocol NumberEXB107-P001
Not yet recruiting
2016-12-01 - 2018-06-30
Phase IV
Terminated1
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
33 participants
-
Global
220 participants
